The growth in this market is majorly attributed to factors such as growing animal population, rising animal healthcare expenditure, rising pet adoption, growing demand for animal-derived food products, rising awareness about zoonotic diseases, and implementation of regulations for preventing the spread of animal diseases.
The Animal
Antibiotics and Antimicrobials Market witnessed significant
growth during the last decade and is expected to grow at a CAGR of 4.6% between
2016 and 2021 to reach 4.73 Billion by 2021.
Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=25161353
The global animal antibiotics and
antimicrobials market is segmented based on product, mode of delivery, animal
type, and geography.
Based on product type, the market is
segmented into tetracyclines, penicillins, sulfonamides, macrolides,
aminoglycosides, cephalosporins, lincosamides, fluoroquinolones, and other
antibiotics and antimicrobials.
Based on mode of delivery, the market is
further categorized into premixes, oral powders, oral solutions, injections,
and other modes of delivery. Based on animal type, the market is segmented into
food-producing animals and companion animals. The food-producing animals
segment is further segmented into cattle, pigs, sheep and goats, poultry, and
other food-producing animals. Similarly, on the basis of geography, the animal
antibiotics and antimicrobials market is segmented into North-America, Europe,
Asia-Pacific, and Rest of the World.
In 2015, the tetracyclines segment
accounted for the largest share of the global animal antibiotics and
antimicrobials market. However, fluoroquinolones segment is expected to witness
the highest growth over the next five years.
North America is the largest regional
segment for animal antibiotics and antimicrobials market owing to the
well-established animal healthcare market. The largest share of this regional
segment is driven by increasing demand for animal-derived food products, rising
animal healthcare expenditure, growing animal population, and rising awareness
about zoonotic diseases.
Speak To Analyst: -https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=25161353
The market players, namely, Zoetis, Inc.
(U.S.), Merck & Co., Inc. (U.S.), Bayer AG (Germany), Eli Lilly and Company
(U.S.), and Virbac (France) held the major share of the animal antibiotics and
antimicrobials market and will continue to dominate the market between 2016 and
2021. Some of the major players competing in this market are Zoetis, Inc.
(U.S.), Bayer AG (Germany), Merck & Co., Inc. (U.S.), Eli Lilly and Company
(U.S.), Virbac (France), Boehringer Ingelheim GmbH (Germany), Ceva Sante Animale
(France), Vetoquinol S.A. (France), Sanofi (France), and Dechra Pharmaceuticals
PLC (U.K.).
No comments:
Post a Comment